Document is current
Any future updates will be listed below
-
Authors
Pei, Siyu
Deng, Xiuyu
Yang, Ruirui
Wang, Hui
Shi, Jian-Hong
Wang, Xueqing
Huang, Jia
Tian, Yu
Wang, Rongjing https://orcid.org/0000-0001-6590-5220
Zhang, Sulin https://orcid.org/0000-0002-9167-4689
Hou, Hui
Xu, Jing
Zhu, Qingcheng
Huang, Huan
Ye, Jialing
Wang, Cong-Yi https://orcid.org/0000-0001-7914-168X
Lu, Wei
Luo, Qingquan https://orcid.org/0000-0003-4098-9477
Ni, Zhi-Yu https://orcid.org/0000-0003-1818-6125
Zheng, Mingyue https://orcid.org/0000-0002-3323-3092
Xiao, Yichuan https://orcid.org/0000-0001-7804-6971
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82425026, 82030041)
National Natural Science Foundation of China (82201921)
National Natural Science Foundation of China (82273463)
National Natural Science Foundation of China (82373072)
- License Information
-
More Information
Article History
Received: 23 October 2023
Accepted: 14 October 2024
First Online: 26 November 2024
Competing interests
: Y.X., M.Z., S.P., X.D., R.Y., S.Z. and H. Hou have filed a patent application regarding the application of the BFAR inhibitor for the treatment of tumors. The other authors declare no competing interests.
